Cure Parkinson’s, in association with Bonhams and Artwise have announced that Cure3, the critically acclaimed selling exhibition devised to raise awareness and funds for curative Parkinson’s research returns for its 5th edition in February 2025.
Featuring highly collectable works by leading artists including Sir Frank Bowling, Rana Begum, Laura Ford, Julian Opie, Bruce McLean, Mona Hatoum and Bouke de Vries, the selling exhibition will take place at Bonhams London, from 1-5th February with VIP Preview on 3rd February. All works will be available to buy online at www.cure3.co.uk with prices for works starting at under £1,000.
The 5th edition of Cure3will be biggest ever staged, with 117 artists generously supporting this much-loved project with original works, specially created in 3 distinctive formats; a 2-dimensional, 20 x 20 cm square or a 20cm3 Perspex box which can act as frame, plinth or container. Finally there will be works by leading generative artists minting NFTs, selected by experts in the field, Foteini Valeonti and Alex Estorick, supported by FX (hash).
It has been incredible to see this event grow and develop since it was first conceived in 2017, and that is down to the hard work and dedication of every person involved, particularly the generous support of the contributing artists without whom the event would not be possible.
Over the last 20 years we have made significant progress towards finding a cure for Parkinson’s and the
Helen Matthews, CEO of Cure Parkinson’s,
almost £2 million that Cure3 has raised to date has played a huge part in helping to drive forward our
mission. There is still much to do but we believe that together, we can conquer Parkinson’s.
All profits from Cure3 help Cure Parkinson’s to fund vital curative research into Parkinson’s; the fastest growing degenerative neurological condition in the world, which effects around 8.5 million people globally.
Co-Founded by Tom Isaacs in 2005, Cure Parkinson’s is a groundbreaking charity created by and for people living with Parkinson’s, with one bold aim – to find a cure for Parkinson’s. Marking its 20th anniversary with their biggest ever edition of Cure3, an initiative supported by 214 artists which has raised almost £2million since its inception in 2017.
Cure3 is devised by Susie Allen and Laura Culpan from Artwise, the dynamic curatorial team behind the original RCA Secret postcard project, Art for Your World and Tomorrow’s Tigers for WWF-UK. Cure3 has established itself as a critical and commercial success, securing plaudits from a host of international media and reaching an estimated global audience in excess of 4.3 billion worldwide.
Artwise, said
“When we started the Cure3 journey back in 2017, we could never have imagined that it would go on to five editions and be supported by over 200 artists, architects, fashion designers and creatives. For this anniversary edition, we are thrilled to welcome back artists who contributed in 2017, as well as introducing a host of new artists, many of whom are exhibiting for the first time in the UK.”
Full list of Artists: HERE
Cure³, 1st-5th February 2025, Bonhams London cure3.co.uk
Format of Selling Exhibition, Cure is not an auction, each art work is individually priced by the artist and sold at this fixed price on line at www.cure3.co.uk.
The works will be on preview at Bonhams from 1st February 2025 and sales will go live online from 6pm on 3rd February. All profits will go directly to Cure Parkinson’s to fund research to slow, stop or reverse Parkinson’s. FOLLOW CURE3 @Cure3Exhibition
More about Parkinson’s and the charity, Cure Parkinson’s
Parkinson’s is a progressive neurological condition with over 40 symptoms, ranging from tremors and slowness of movement to chronic pain, which affects over 145,000 people in the UK and 8.5 million people worldwide. With the prevalence of Parkinson’s doubling in the past 25 years, there has never been a more urgent need to support the ongoing work of Cure Parkinson’s – an organisation which has been at the forefront of driving curative research since 2005.
By the end of 2025 Cure Parkinson’s will have committed more than £19.4m funding for Parkinson’s research in over 80 separate research projects and more than 5,000 people have taken part in clinical trials of drugs evaluated by Cure Parkinson’s iLCT programme. This programme evaluates and prioritises both new drugs and drugs already in use to treat other conditions, for their potential to treat Parkinson’s, with the charity supporting two of only three phase 3 disease-modifying trials for Parkinson’s worldwide.
As we enter our 20th year, the charity is more determined than ever to drive forward Tom’s vision and we can report exciting progress in the Parkinson’s research landscape. In 2025, Cure Parkinson’s will launch and fund its biggest ever research project, with thousands of people with Parkinson’s taking part. These revolutionary, new multi-arm, multi-stage clinical trials will allow the testing of multiple treatments at the same time, speeding up the clinical trial process significantly.
Starting with Cure3, Cure Parkinson’s will be marking its 20th anniversary with a series of fundraising events throughout the year. The funds raised willsupport the essential work carried out by the charity and offer hope to millions of people currently living with the condition. In 2005, the goal of Cure Parkinson’s was to render the charity redundant by finding a cure for the condition – in 2025 our aim is to fulfil the dream of Tom Isaacs and finally consign Parkinson’s to a disease of the past.
